Waelkens E, Gettemans J, De Corte V, De Ville Y, Goris J, Vandekerckhove J, Merlevede W
Afdeling Biochemie, Faculteit Geneeskunde, Katholieke Universiteit te Leuven, Belgium.
Adv Enzyme Regul. 1995;35:199-227. doi: 10.1016/0065-2571(94)00013-s.
Based on the phosphorylation of the purified actin-fragmin complex, an 80 kDa monomeric kinase (AFK) has been isolated from Physarum polycephalum. Protein chemical analysis and studies involving kinase inhibitors and effectors establish that the AFK is a unique kinase that cannot be classified so far in one of the conventional kinase families. The actin-fragmin kinase behaves as an "independent" kinase since its activity towards the actin-fragmin complex is apparently not regulated by the binding of a ligand (e.g., the cyclic-nucleotides, Ca2+, calmodulin, phosphatidylserine and diolein). Rigorous screening of the substrate specificity suggests that the actin-fragmin complex represents the only substrate for this kinase. This kinase phosphorylates the actin moiety of the actin-fragmin complex at two consecutive threonine residues which constitute one of the contact sites for DNase I (37) and which are also located at one of the proposed actin-actin contact sites along the long-pitch helix of F-actin (38, 39). The physiological importance of this phosphorylation was demonstrated by studying the effect of phosphorylation on the nucleation and the capping activity of the actin-fragmin complex using fluorescence enhancement analysis. As could be demonstrated, the nucleation of actin filaments by the actin-fragmin complex is completely abolished upon phosphorylation by the AFK. Phosphorylation of the complex also interferes with its capping activity, which becomes Ca(2+)-dependent. In addition, capping and nucleating activity is regulated in vitro by phosphoinositides, of which PIP2 displays the highest activity and specificity. PIP2 partially inhibits the nucleation and capping activity of the unphosphorylated actin-fragmin. The capping activity of the phosphorylated actin-fragmin complex was inhibited by PIP2 to a much greater extent as compared to the unphosphorylated actin-fragmin complex. Among all phospholipids tested, PIP2 displayed the highest specificity. Initial experiments with purified preparations of the PP-1, PP-2A, PP-2B, alkaline phosphatase and acid phosphatases showed that PP-1 and PP-2A phosphatases were capable of dephosphorylating the phospho actin-fragmin complex. These findings raised the question of whether these or other protein phosphatases were involved in the dephosphorylation of this substrate in vivo. To address this question, Physarum extracts were subjected to fractionation by ion exchange chromatography, and the column fractions were assayed in a variety of conditions, to identify the protein phosphatases involved in the dephosphorylation of this substrate and to identify the elution position of the major Ser/Thr protein phosphatases present in the Physarum extract.(ABSTRACT TRUNCATED AT 400 WORDS)
基于纯化的肌动蛋白 - 凝溶胶蛋白复合物的磷酸化作用,已从多头绒泡菌中分离出一种80 kDa的单体激酶(AFK)。蛋白质化学分析以及涉及激酶抑制剂和效应物的研究表明,AFK是一种独特的激酶,目前无法归类到传统激酶家族中的任何一类。肌动蛋白 - 凝溶胶蛋白激酶表现为一种“独立”激酶,因为其对肌动蛋白 - 凝溶胶蛋白复合物的活性显然不受配体(如环核苷酸、Ca2 +、钙调蛋白、磷脂酰丝氨酸和二油精)结合的调节。对底物特异性的严格筛选表明,肌动蛋白 - 凝溶胶蛋白复合物是该激酶的唯一底物。该激酶在肌动蛋白 - 凝溶胶蛋白复合物的肌动蛋白部分的两个连续苏氨酸残基上进行磷酸化,这两个残基构成了DNase I的一个接触位点(37),并且也位于沿F - 肌动蛋白长间距螺旋的拟议肌动蛋白 - 肌动蛋白接触位点之一(38,39)。通过使用荧光增强分析研究磷酸化对肌动蛋白 - 凝溶胶蛋白复合物的成核和封端活性的影响,证明了这种磷酸化的生理重要性。可以证明,AFK磷酸化后,肌动蛋白 - 凝溶胶蛋白复合物对肌动蛋白丝的成核作用完全被消除。复合物的磷酸化也会干扰其封端活性,使其变为Ca(2 +)依赖性。此外,封端和成核活性在体外受磷酸肌醇调节,其中PIP2表现出最高的活性和特异性。PIP2部分抑制未磷酸化的肌动蛋白 - 凝溶胶蛋白的成核和封端活性。与未磷酸化的肌动蛋白 - 凝溶胶蛋白复合物相比,PIP2对磷酸化的肌动蛋白 - 凝溶胶蛋白复合物的封端活性抑制作用更大。在所有测试的磷脂中,PIP2表现出最高的特异性。对PP - 1、PP - 2A、PP - 2B、碱性磷酸酶和酸性磷酸酶的纯化制剂进行的初步实验表明,PP - 1和PP - 2A磷酸酶能够使磷酸化的肌动蛋白 - 凝溶胶蛋白复合物去磷酸化。这些发现提出了一个问题,即这些或其他蛋白磷酸酶是否参与了该底物在体内的去磷酸化过程。为了解决这个问题,对多头绒泡菌提取物进行离子交换色谱分级分离,并在各种条件下对柱级分进行检测,以鉴定参与该底物去磷酸化的蛋白磷酸酶,并确定多头绒泡菌提取物中主要的丝氨酸/苏氨酸蛋白磷酸酶的洗脱位置。(摘要截断于400字)